Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders.

OBJECTIVE Arthritis in the K/BxN mouse model results from pathogenic immunoglobulins that recognize glucose-6-phosphate isomerase (GPI), a glycolytic enzyme residing in the cytoplasm of all cells. Antibodies directed against GPI can, alone, transfer arthritis to healthy recipients. Previous experiments have revealed significant titers of anti-GPI antibodies in the serum of many patients with rheumatoid arthritis (RA). We evaluated the generality of these observations in cohorts of patients with 12 different arthritic and chronic autoimmune diseases and in population-matched healthy control subjects. METHODS Anti-GPI antibodies were assayed in 811 individual serum samples by enzyme-linked immunosorbent assay with 2 forms of GPI, recombinant and native. Results were confirmed by immunoblotting. RESULTS Several patients had significantly elevated anti-GPI antibody titers, but without the prevalence or the specificity reported previously. Only 15% of RA patients had anti-GPI antibodies (range 12-29% in different cohorts), with a higher prevalence in patients with active disease. Psoriatic arthritis, undifferentiated arthritis, and spondylarthropathy patients also displayed anti-GPI antibodies at similar frequencies (12-25%). Similar titers were detected in a proportion (5-10%) of control subjects or patients with Crohn's disease or sarcoidosis. Very high titers were found in rare cases of RA and systemic lupus erythematosus. CONCLUSION No disease-specific pattern of antibody positivity to GPI was apparent. While the antibody-mediated mechanism at play in the mouse model may exemplify a generic mechanism for some forms of arthritis in humans, GPI itself does not appear to be a target common to the majority of RA patients.

[1]  C. Benoist,et al.  Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis , 2002, The Journal of experimental medicine.

[2]  P. Jungblut,et al.  Autoantibodies to GPI and creatine kinase in RA , 2002, Nature Immunology.

[3]  Daniela Kassahn,et al.  Few human autoimmune sera detect GPI , 2002, Nature Immunology.

[4]  H. Ditzel,et al.  Response to 'Autoantibodies to GPI and creatine kinase in RA' and 'Few human autoimmune sera detect GPI' , 2002, Nature Immunology.

[5]  C. Benoist,et al.  Arthritogenic Monoclonal Antibodies from K/BxN Mice , 2002, The Journal of experimental medicine.

[6]  C. Benoist,et al.  How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease , 2002, Nature Immunology.

[7]  G. Firestein,et al.  How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end. , 2002, Arthritis and rheumatism.

[8]  Ralph Weissleder,et al.  Arthritis critically dependent on innate immune system players. , 2002, Immunity.

[9]  D. Burton,et al.  Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease , 2001, Nature Immunology.

[10]  D. Fremont,et al.  Molecular Basis for Recognition of an Arthritic Peptide and a Foreign Epitope on Distinct MHC Molecules by a Single TCR1 , 2000, The Journal of Immunology.

[11]  H. Schumacher,et al.  Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset , 2000, Arthritis research.

[12]  C. Benoist,et al.  A revival of the B cell paradigm for rheumatoid arthritis pathogenesis? , 2000, Arthritis research.

[13]  C. Benoist,et al.  Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. , 1999, Science.

[14]  K. Rajewsky,et al.  From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. , 1999, Immunity.

[15]  N. Kalkkinen,et al.  Purification of Filaggrin from Human Epidermis and Measurement of Antifilaggrin Autoantibodies in Sera from Patients with Rheumatoid Arthritis by an Enzyme-Linked Immunosorbent Assay , 1998, International Archives of Allergy and Immunology.

[16]  V. Kouskoff,et al.  Organ-Specific Disease Provoked by Systemic Autoimmunity , 1996, Cell.

[17]  J. Durieux,et al.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. , 1995, The Journal of clinical investigation.

[18]  H. Ménard,et al.  The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. , 1994, The Journal of rheumatology.

[19]  D. Veale,et al.  Classification of clinical subsets in psoriatic arthritis. , 1994, British journal of rheumatology.

[20]  M. Dougados,et al.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. , 1991, Arthritis and rheumatism.

[21]  G. Firestein,et al.  How important are T cells in chronic rheumatoid synovitis? , 1990, Arthritis and rheumatism.

[22]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[23]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[24]  J. Fries,et al.  A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. , 1986, Arthritis and rheumatism.

[25]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[26]  F. V. D. van den Hoogen,et al.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. , 1998, The Journal of clinical investigation.

[27]  M. Feldmann,et al.  Rheumatoid Arthritis , 1996, Cell.

[28]  M. Akizuki,et al.  Criteria for Sjögren's syndrome in Japan. , 1986, Scandinavian journal of rheumatology. Supplement.